PD-1, interacting with its ligand PD-L1 on tumor cells and antigen-presenting cells, and PD-L2 on activated monocytes and dendritic cells, inhibits T cell activity, thereby regulating immune tolerance. The gene discussed is CD274; the disease is neoplasm.